Drug Shortage Report for SODIUM BICARBONATE INJECTION USP
| Report ID | 34276 |
| Drug Identification Number | 00261971 |
| Brand name | SODIUM BICARBONATE INJECTION USP |
| Common or Proper name | SODIUM BICARBONATE INJECTION LIFESHIELD 4.2% |
| Company Name | PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | SODIUM BICARBONATE |
| Strength(s) | 42MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 10x10mL |
| ATC code | B05XA |
| ATC description | I.V. SOLUTION ADDITIVES |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2018-01-19 |
| Estimated end date | |
| Actual end date | 2018-02-02 |
| Shortage status | Resolved |
| Updated date | 2018-02-07 |
| Company comments | |
| Health Canada comments | |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.